Navigation Links
Type 2 diabetes study to examine role amylin plays in disease

WASHINGTONA George Washington University researcher will receive $1.3 million over the next five years from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for research that will help better understand how type 2 diabetes develops, possibly informing the development of novel treatments to reverse the disease.

The research is particularly important given 150 million people worldwide suffer from type 2 diabetes--a number expected to double over the next 20 years.

Aleksandar Jeremic, an associate professor of biology in the Columbian College of Arts and Sciences, along with a team of GW undergraduate students, graduate students and postdoctoral fellows, will study the role amylin--a hormone that, like insulin, is secreted by the pancreas to regulate blood sugar levels--plays in the development of type 2 diabetes. When amylin aggregates in the pancreas and forms protein deposits, it can kill insulin-producing beta-cells, leading to type 2 diabetes.

Using high-resolution imaging approaches such as confocal and atomic force microscopy, which can produce a scan at the nanometer resolution, the GW team will investigate the molecular and biochemical events that lead to the aggregation of human amylin.

"We know of many factors, such as poor diet and inactivity, that contribute to type 2 diabetes," Dr. Jeremic said. "What is less clear, but no less important, is the role amylin plays in the development of the disease. Our research may also provide a better understanding of the biological role of this important signaling molecule in the human body."

Ultimately, the information could contribute to new treatments for type 2 diabetes, for example, by preventing the aggregation of amylin or making cells less susceptible to the toxic effects of the buildup.

The project, "Molecular Mechanisms of Amylin Trafficking and Toxicity in Human Pancreatic Islets," NIH grant R01DK091845, will be funded by the NIDDK, part of the National Institutes of Health, for the next five years.


Contact: Kurtis Hiatt
George Washington University

Related biology news :

1. ITN type 1 diabetes study identifies subset of patients with strong response to therapy
2. Obesity and mortality association differs between individuals with and without diabetes
3. Healthrageous, United BioSource And Boehringer Ingelheim Launch SMART Digital Diabetes Study
4. Diet additions may help youth with type 1 diabetes keep producing own insulin
5. DNA abnormalities may contribute to cancer risk in people with type 2 diabetes
6. Infants food linked to higher, lower Type 1 diabetes risk
7. Type 2 diabetes patients transplanted with own bone marrow stem cells reduces insulin use
8. National Institutes of Health to fund research probing proteins linked to cancer, diabetes
9. Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies
10. New data on islet autoantibodies in young children defines early type 1 diabetes development
11. Breakthrough research of essential molecule reveals important targets in diabetes and obesity
Post Your Comments:
(Date:11/9/2015)... ) ... "Global Law Enforcement Biometrics Market 2015-2019" ... ) has announced the addition of ... 2015-2019" report to their offering. ... ) has announced the addition of the ...
(Date:11/4/2015)... 2015 --> ... by Transparency Market Research "Home Security Solutions Market - Global ... - 2022", the global home security solutions market is expected to ... The market is estimated to expand at a CAGR ... 2022. Rising security needs among customers at homes, the ...
(Date:10/29/2015)... Minn. , Oct. 29, 2015   MedNet ... supports the entire spectrum of clinical research, is pleased ... Minnesota High Tech Association (MHTA) as one of only ... in the "Software – Small and Growing" category. The Tekne ... individuals who have shown superior technology innovation and leadership. ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... , Nov. 24, 2015 According to two new ... 2005. This is something that many doctors, scientists, and public ... questions remains: with fewer PSA tests being done, will there ... Dr. David Samadi, "Despite the efforts made ... remains the second leading cancer cause of death in men, ...
(Date:11/23/2015)... HONG KONG, Nov. 23, 2015 China Cord ... "Company"), China,s leading provider of cord blood collection, laboratory ... services, today announced its preliminary unaudited financial results for ... 2016 ended September 30, 2015. --> ... Highlights , Revenues for the second quarter of ...
(Date:11/23/2015)... 23, 2015 The royalty-free a ... to develop daclatasvir for 112 low- and ... --> --> The Medicines Patent ... C medicine, signing an agreement with Bristol-Myers Squibb for daclatasvir, ... multiple genotypes of the HCV virus.  The royalty-free licence will ...
(Date:11/23/2015)... Nov. 23, 2015  CryoLife, Inc. (NYSE: CRY ), ... cardiac and vascular surgery, announced today that it will participate ... Conference on Wednesday, December 2, 2015 at The New York ... Pat Mackin , President and Chief Executive Officer. ... Executive Officer. --> A live webcast of ...
Breaking Biology Technology: